The purinergic receptor system plays an important role in the regulation of both vascular and tubular functions within the kidney; however, the release of purinergic agonists other than ATP by renal tissue is not known. In this investigation, we determine if kidney tissue is a source of diadenosine polyphosphates, which have high affinity for the P 2X and P 2Y receptors. Both diadenosine pentaphosphate and hexaphosphate were identified by matrix-assisted laser desorption ionization-mass spectrometry in extracts purified from both whole porcine kidney and from cloned cells of the LLC-PK1 cell line. Both polyphosphates in nanomolar concentrations were found to significantly stimulate the proliferation of vascular smooth muscle cells derived from rat thoracic aortas. The purinergic-receptor antagonist, suramin, did not significantly affect the growth-stimulatory properties of the polyphosphates. The growth stimulation of vascular smooth muscle cells by platelet-derived growth factor was potentiated by both diadenosine polyphosphates. We conclude that diadenosine polyphosphates are endogenous purinergic agonists of the kidney that have physiologic and pathophysiologic relevance. These epithelial cell metabolic products have vasoregulatory properties while linking the energy supply and tubular function. 1 Numerous tubular functions are regulated via purinergic mechanisms. Luminal P 2Y receptors are expressed along the whole distal nephron down to inner medullary collecting duct.
Purinergic signalling importantly contributes to the control of renal vascular and tubular function. Afferent arteriolar tone is under control of P 2X1 receptors, effecting fine-tuning of glomerular perfusion and filtration. 1 Numerous tubular functions are regulated via purinergic mechanisms. Luminal P 2Y receptors are expressed along the whole distal nephron down to inner medullary collecting duct.
2 P 2Y2 receptors are the predominant subtype in the distal nephron, but P 2Y1 , P 2Y4 , and P 2Y6 subtypes have also been found. 3 Multiple tubular functions are mediated by P 2Y receptors. Luminal nucleotides increase cytosolic-free Ca 2 þ concentration and, thereby, inhibit Na þ and Ca 2 þ reabsorption and stimulate Cl secretion. 4, 5 Purinergic inhibition of distal Na þ reabsorption is mediated by inhibition of basolateral Na-K-Cl cotransport and of amiloride-sensitive Na þ reabsorption. 4, 6 Moreover, purinergic regulation of K þ secretion via renal outer medullary potassium channels (ROMK channels) and on aquaporin-2-mediated water transport has been described. 7, 8 Proximal tubular P 2 receptor expression is less clear. 2 Given that purinergic signalling plays an important role in the regulation of tubular function, the question arises as to the source of nucleotide messengers active in renal tissue. Luminal secretion of ATP by epithelial cells has been demonstrated, 9 but nothing is known regarding the secretion of other nucleotides. We examined, therefore, whether renal tissue is the source of a specific group of endogenous purinergic agonists, the diadenosine polyphosphates. These endogenous nucleotides have recently attracted growing interest as they show high affinities to specific P 2X and P 2Y receptor subtypes. 10 Lacking free phosphate groups, diadenosine polyphosphates are much more resistant to extracellular degradation than mononucleoside polyphosphates. 11 This study reveals that diadenosine pentaphosphate (Ap 5 A) and diadenosine hexaphosphate (Ap 6 A) are components of renal tissue and renal proximal tubule cells obviously secrete these mediators on stimulation. These findings suggest that autocrine purinergic control of vascular and tubular functions by complex nucleotides may be of physiological and pathophysiological relevance, providing a link between tubular function and energy supply as well as other functions of the vascular system like infiltration of blood cells to the interstitial space.
RESULTS
The anion-exchange chromatogram obtained from a selected fraction of the displacement-chromatography is given in Figure 1a . The eluate of the anion-exchange chromatography was fractionated by reversed-phase chromatography. Figure 1b shows a reversed-phase chromatography from the peak labelled in Figure 1a . As in the preceding chromatographic step, this fraction was chosen on the basis of the retention time typical for diadenosine polyphosphates in this chromatographic setting. The fraction labelled by an arrow in Figure 1b was rechromatographed by reversed-phase chromatography using the same conditions as before. In the last chromatographic step, a single UV peak was obtained (data not shown). The molecular structure of the underlying substance was determined by matrix-assisted laser desorption ionization-mass spectrometry using the methods and condition described previously. 12, 13 Hereby, the underlying substance was identified as Ap 5 A and Ap 6 A. After identification of Ap 5 A and Ap 6 A from porcine kidneys, Ap 5 A and Ap 6 A were isolated and identified from human kidney tissue too.
After we had identified Ap 5 A and Ap 6 A in extracts from renal tissue, the question arose as to which renal cells are the source of diadenosine polyphosphates. As epithelial cells have been shown to secrete Ap 5 A and Ap 6 A, we examined whether cultured renal proximal tubule cells secrete diadenosine polyphosphates on stimulation. (Figure 3a) . The effect of Ap 5 A and Ap 6 A on VSMC proliferation was confirmed by cell counting ( Table 1) .
The growth-stimulating effect of Ap 5 A and Ap 6 A was not significantly inhibited by both the purinergic-receptor antagonist, suramin ([ 3 H]-thymidine uptake of 118.077.0 versus 105.078.0% above control) and pyridoxalphosphate-6-azophenyl-2,4-disulphonic acid (93.974.5 versus 96.376.8 % above control) indicating that suramin-and pyridoxalphosphate-6-azophenyl-2,4-disulphonic acid-insensitive receptors may be involved in the growth-promoting effect.
After Ap 5 A and Ap 6 A had been shown to stimulate growth of VSMCs, the interaction of these substances with PDGF was also examined. As shown in Figure 3b , the effect of PDGF on VSMC growth was markedly enhanced (Po0.001). o r i g i n a l a r t i c l e V Jankowski et al.: Diadenosine polyphosphates in renal tissue
DISCUSSION
The results of this study document that renal tissue contains significant amounts of diadenosine polyphosphates and that tubular cells are one of the sources of these diadenosine polyphosphates. It is already well-known that diadenosine polyphosphates are released into the circulation from activated platelets [14] [15] [16] from chromaffin cells of the adrenal glands, [17] [18] [19] heart tissue, 20 and from synaptic vesicles 21 and that they act as strong vasoconstrictive substances, mostly mediated by P 2X receptors (e.g., van der Giet et al. 22, 23 ), and have strong regulatory properties on the growth of mesangial cells. 24 Kidney tissue is obviously a further important source releasing diadenosine polyphosphates after stimulation. These diadenosine polyphosphates have not only strong vasoconstrictive properties but also act as strong growthstimulating mediators of VSMCs. These results confirm previous data suggesting stimulation of vascular growth by diadenosine polyphosphates. 25 Ap 5 A and Ap 6 A markedly enhanced the DNA and RNA synthesis, but not the protein synthesis induced by PDGF. These findings suggest that Ap 5 A and Ap 6 A function by a different pathway than PDGF, which may act as a regulatory factor, that is, in the initial phase of the mitogenic cycle preceding the DNA synthesis.
Is there a role for tubular diadenosine polyphosphates acting on renal vasculature? Given the close vicinity of tubules and peritubular vessels, a paracrine function for diadenosine polyphosphates secreted by renal tubules is not unlikely. Moreover, the high-energy consumption by renal tubular cells necessitates a feedback regulation of vascular supply by renal tubules. Diadenosine polyphosphatesinduced VSMC proliferation may be one element playing a role in tubular vasoregulation, providing a link between tubular function and energy supply as well as other cell functions like the infiltration of blood cells to the interstitial space, especially in pathophysiological conditions.
What is the relevance of these findings for renal pathophysiology? The understanding of purinergic mechanisms in the regulation of tubular and renal vascular functions is at its very beginning. At present, studies mainly focus on the role of ATP as a purinergic agonist. As it has been well documented that diadenosine polyphosphates show a profile of action different from that of ATP and other mononucleotides, 10, 26, 27 diadenosine polyphosphates may play a specific role in the purinergic regulation of renal functions. The renal actions of diadenosine polyphosphates may be mediated by purine receptors both in the renal epithelia and renal vasculature.
Which purinergic receptors may be involved in this process? Renal diadenosine polyphosphates may mediate important actions via P 2X receptors located on renal microvessels. It has been already demonstrated that the autoregulatory constriction of afferent glomerular arterioles is largely mediated by P 2X1 receptors 1 and that diadenosine polyphosphates are strong agonists of P 2X1 receptors. 27, 28 Hence, diadenosine polyphosphates may play a significant role in pressure-induced afferent arteriolar autoregulatory responses. Given that diadenosine polyphosphates act on P 2X1 receptors with a much higher affinity and a much longer half-life than ATP, diadenosine polyphosphates may importantly contribute to renal vasoregulation.
Moreover, in renal epithelial cells, multiple P 2Y receptor subtypes are expressed, which vary along the different segments of the nephron. The precise role of each P 2Y -receptor subtype has not yet been elucidated. P 2Y1 , P 2Y2 , and P 2Y6 receptors have been demonstrated in renal epithelia; 3, 29 however, these receptors are thought to be implicated in regulating salt and water balance. P 2Y stimulation results in increased salt and water excretion, suggesting a role of these receptors in hypertension and in disorders of volume regulation. 7 Diadenosine polyphosphates decrease energy-consuming processes like tubular Na þ reabsorption and effectively stimulate diuresis. 30 It is very likely that the stimulatory effect of diadenosine polyphosphates on VSMC growth is mediated by P 2Y receptors. 31 The metabolism of the diadenosine polyphosphates has not been clarified yet, but it has been suggested that these agents are cleaved by phosphodiesterases, 32 meaning that the diadenosine polyphosphates may be cleaved asymmetrically. This indicates that the effects of Ap 5 A and Ap 6 A could be produced by ATP generated from the diadenosine polyphosphates. However, this possibility seems unlikely, as both diadenosine polyphosphates are effective in much lower concentrations than ATP.
In conclusion, diadenosine polyphosphates stimulate cell proliferation and, hence, regenerative processes. Therefore, the physiological effects of diadenosine polyphosphates may be explained by the combined effects of P 2 receptor stimulation in the renal epithelia and renal vasculature. Thus, diadenosine polyphosphates secreted by renal tubular epithelia may function as autocrine and paracrine messengers mediating important regulative processes in renal physiology and pathology.
Furthermore, our experiments show that renal tissue contains significant amounts of Ap 5 A and Ap 6 A. These nucleotide messengers probably mediate purinergic effects on renal vascular function. In addition to the well-known P 2X receptor-mediated actions on vasculature and tubules, Ap 5 A and Ap 6 A are potent stimulators of VSMC growth and, thus, may contribute to remodelling processes in renal tissue. It remains to be clarified whether this process can be characterized as a protective or noxious effect.
MATERIALS AND METHODS Materials
High-pressure liquid chromatography water (gradient grade) and acetonitrile were from Merck (Darmstadt, Germany). All other substances were purchased from Sigma (Taufkirchen, Germany), unless otherwise indicated.
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Purification procedures of AP 5 A and AP 6 A from renal tissue Firstly, porcine kidneys were purchased from a local slaughterhouse. Kidney tissue was immediately placed in ice-cold physiological saline and cut into small pieces. Tissue was frozen, lyophilized, and powdered. Twenty grams of tissue (dry weight) was homogenated with perchloric acid. Treatment of the cells with perchloric acid prevented enzymatic degradation of diadenosine polyphosphates and removed most proteins. The extract was centrifuged at 100 000 g and the supernatant was neutralized with KOH to pH 9.5.
The chromatographic procedure for the isolation of diadenosine polyphosphates is comparable to previously described methods (see Jankowski et al. 12, 13 ). The purification strategy detailed in the following is a modification of procedures, which were developed for the isolation of diadenosine polyphosphates in earlier studies. 12, 13 Briefly, the extract from renal tissue was fractionated by size-exclusion chromatography. Afterwards, the mononucleoside polyphosphates and dinucleoside polyphosphates of the low-molecular weightcontaining fractions of the size-exclusion chromatography were separated by affinity chromatography. Next, the desalted and lyophilized eluate of the affinity chromatography was fractionated by reversed-phase displacement chromatography. The fractions resulting from the displacement chromatography were fractionated by anion-exchange chromatography.
After centrifugation, strong hydrophilic substances as well as strong hydrophobic substances were separated from the dinucleoside polyphosphates by reversed-phase chromatography. For this, triethylammonium acetate was added to the extract of kidney tissue. The supernatant was pumped through a preparative reversed-phase column (Lichroprep, 310 Â 65 mm, 40-65 mm; Merck, Germany). After removing substances not binding to the column with aqueous 40 mmol/l triethylammonium acetate, the absorbed molecules were eluted with 20% acetonitrile in water. The elution was detected by measuring the UV absorption at 254 nm.
The eluate was lyophilized and fractionated by size-exclusion chromatography using water as eluent. This eluent repulsion and the adsorption effects of the size-exclusion gel reinforce each other leading to repulsion of the anionic diadenosine polyphosphates by the carboxyl group of the gel. As a result, diadenosine polyphosphates elute earlier than one would expect, based on their molecular weight. The lyophilized samples from the reversed-phase column were dissolved in 5 ml water and were loaded to a sizeexclusion gel (Sephacryl S-100; Pharmacia, Uppsala, Sweden). The effluate was monitored with a UV detector at 254 nm.
Next, the fraction eluted from the size-exclusion gel was passed through a phenylboronic acid affinity column. The affinity chromatography gel specifically binds dinucleoside polyphosphates discriminating against mononucleoside polyphosphates. Binding substances were eluted with 10 mmol/l HCl. The desalted eluate of the affinity chromatography was injected on a C18 reversed-phase column (Supersphere C18 endcapped, 100 Â 2.1 mm, 4 mm; Merck, Germany). The carrier was pumped through the system at a flow rate of 10 ml/min. After the injection was completed, n-butanol (160 mmol/l) was used as displacer. The fraction size was 100 ml. For further purification, fractions of the displacement chromatography were selected according to the retention time shown to be typical for diadenosine polyphosphates in earlier studies using the same chromatographic procedure. 12, 14 Afterwards, the fractions from the displacement chromatography were fractionated by anion-exchange chromatography. The anion-exchange column (Mono-Q PC3.2/2. 32 Â 2 mm; Pharmacia, Sweden) was equilibrated with eluent A (20 mmol/l K 2 HPO 4 , pH 8.0). The sample dissolved in eluent A was injected to the column. Binding substances were eluted using a linear gradient with increasing concentration of eluent B (20 mmol/l K 2 HPO 4 with 1 mol/l NaCl, pH 8.0).
The fractions from anion-exchange chromatography were further separated by reversed-phase high-pressure liquid chromatography (Supersphere 100 RP C18 endcapped, 250 Â 4 mm; Merck, Germany). The fractions dissolved in eluent A (40 mmol/l triethylammonium acetate in water) were injected to the highpressure liquid chromatography. The pH of the samples was titrated to 6.5 with HCl. Binding substances were eluted by a linear gradient. Fractions with a significant UV absorption at 254 nm were rechromatographed using the condition as described.
The lyophilized fractions from the reversed-phase chromatography were examined by matrix-assisted laser desorption ionization-mass spectrometry and by enzymatic cleavage experiments as described. 13, 33 Afterwards, human renal tissue was extracted as described above. The extract was fractionated by preparative and analytic reversedphase and affinity chromatography as described above.
VSMC culture and proliferation assays Vascular smooth muscle cells (VSMCs) were obtained from thoracic aortas of normotensive Wistar-Kyoto rats and cultured by the tissueexplant method. 34, 35 Briefly, cells were incubated in Dulbecco's modified Eagle's medium (Gibco, Karlsruhe, Germany). Cultures were incubated at 371C. When VSMCs had formed a confluent monolayer, they were harvested by adding 0.05% trypsin and the culture was continued up to eight passages. 36 To ascertain that cultured cells were VSMCs, immunocytochemical localization of aactin was carried out. 36 Immunocytochemical staining of cells with antibodies against von-Willebrand factor confirmed that cultured VSMCs were free from contamination.
VSMCs were subcultured at a density of 5 Â 10 4 cells/ml and kept in culture medium containing 10% fetal calf serum to reach a subconfluent monolayer. Cell growth was arrested by transferring them into 0.5% fetal calf serum. Quiescent VSMCs were then exposed to fresh culture medium with and without Ap 5 A, Ap 6 A, ATP, uridine triphosphate, and a, b-methylene ATP (each 10 À9 -10 À5 mol/l), respectively. After incubation, VSMCs were pulsed with 2 mCi/ml [ 3 H]-thymidine, trypsinized, and harvested onto filter paper. Incorporated counts were measured by a scintillation counter.
In separate experiments, VSMCs were incubated with diadenosine polyphosphates in the presence or absence of suramin (100 mmol/l) 37, 38 and pyridoxalphosphate-6-azophenyl-2,4-disulphonic acid (10 mmol/l), respectively.
Furthermore, VSMCs were incubated in the presence of 5 ng/ml platelet-derived growth factor (PDGF) in presence or absence of 10 mmol/l Ap 5 A and Ap 6 A, respectively. Additional experiments for estimation of cell growth were performed by counting VSMC numbers microscopically and by measuring [
3 H]-thymidine-incorporation into acid-precipitable material. All experiments gave results comparable to the aforementioned method. Moreover, the VSMCs were pulsed with 2 mCi/ml [ 3 H]-uridine for determination of RNA synthesis or 2 mCi/ml [ 3 H]-leucine for quantitation of protein synthesis. 39 The cells were analyzed as described above. LGC Promochem, Wesel, Germany) were maintained in keratocyte serum-free-medium (GIBCO BRL, Germany) supplemented with 5 ng/ml epidermal growth factor, 40 ng/ml bovine pituitary extract, 100 IU/ml penicillin, and 100 mg/ml streptomycin. Both cells lines were maintained in a 5% CO 2 incubator at 371C. For all experiments, LLC-PK 10 cells were grown to confluency and HK-2 cells to approximately 80% confluency. In both cell lines, before stimulation with 1-oleoyl-2-acetylglycerol (OAG), medium was discarded and the cells cautiously rinsed three times with warm phosphate-buffered saline (PBS). Thereafter, LLC-PK 10 cells were stimulated at 201C on a rocker (i) with 500 nmol OAG dissolved in PBS for 1, 5, 10, or 20 min or (ii) with 100, 500, and 1000 nmol OAG dissolved in PBS for 10 min.
HK-2 cells were stimulated at 201C on a rocker with 500 nmol OAG dissolved in PBS for 10 min. Collection and processing of the supernatants of five cell flasks for each experiment as well as control experiments were performed as described for isolated proximal tubules.
After incubation, aliquots of the supernatant were immediately stored on ice and perchloric acid added for protein precipitation. The samples were gently stirred and centrifuged. The supernatant of five cell flasks was collected, adjusted to pH 10, and samples were frozen. For control experiments, five cell flasks with LLC-PK 10 cells were treated similarly, but OAG was omitted, and cells were only incubated with PBS.
Afterwards, the supernatants were chromatographed for isolation of Ap 5 A and Ap 6 A. First, the supernatants of proximal tubule cells were concentrated by preparative reversed-phase chromatography using two analytic reversed-phase columns (Chromolith, 100 Â 4.6 mm; Merck, Germany). As an internal standard, 10 mg ApcpcpA was used. The retained substances were fractionated by water with 40 mmol/l triethylammonium acetate as ion-pair reagent as eluent A and 80% acetonitrile in water as eluent B by a step-wise gradient. The eluate of the analytical reversed-phase chromatography was fractionated by affinity chromatography as described above. The eluate of the affinity chromatography gel was fractionated by two reversed-phase high-pressure liquid chromatography columns (Chromolith, 100 Â 4.6 mm; Merck, Germany) using the chromatographic methods as described above. The amount of Ap 5 A and Ap 6 A was quantified by matrix-assisted laser desorption ionization-mass spectrometry. 40 Isolated proximal tubules Next, the Ap 5 A and Ap 6 A secretation of isolated rat proximal tubules were analyzed. Rat proximal tubules were freshly isolated as recently described. 41 Male Sprague-Dawley rats (220-300 g of body weight) were anesthetized with ketaminhydrochloride (100 mg/kg body weight, intraperitoneally) and xylazinhydrochloride (5 mg/kg body weight, intraperitoneally) and abdominal incision was performed. The renal arteries were cannulated and flushed with 40 ml of ice-cold (41C), oxygenated, and heparinized (1% of a 5000 I.E./ml heparin solution) buffer solution A containing (in mmol/l): 112 NaCl, 20 NaHCO 3 , 5 KCl, 1.6 CaCl 2 , 2 NaH 2 PO 4 , 1.2 MgSO 4 , 5 glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 10 mannitol, 1 glutamine, 1 sodium butyrate, 1 sodium lactate, adjusted to pH 7.3 at 371C. Perfusion was continued with 30 ml of ice-cold solution A containing 5 mg of collagenase and 12.5 mg of hyaluronidase (Boehringer Biochemical, Mannheim, Germany). After perfusion, the kidneys were removed and transferred into ice-cold solution A. Renal cortices were dissected and minced on an ice-cold Petri dish. Tissue fragments were washed twice with 50 ml of oxygenated solution A followed by incubation for 30 min with 30 ml of oxygenated solution A containing 10 mg collagenase and 7.5 mg of hyaluronidase in a shaking water bath at 371C. Digestion was stopped by incubation in 15 ml of ice-cold solution A containing 0.5 g of fatty acid free bovine serum albumin (Serva, Heidelberg, Germany). After filtering the tissue through a tea strainer and washing to remove the albumin, proximal tubules were separated by percoll gradient centrifugation (10 min at 11 000 g), using 45% percoll (Pharmacia, Sweden). Proximal tubules were recovered from the lowest band, which was primarily composed of proximal tubules (495%) without containing glomeruli. Tubules were suspended in oxygenated solution B, containing (in mmol/l): 106 NaCl, 20 NaHCO 3 , 5 KCl, 1 CaCl 2 , 2 NaH 2 PO 4 , 1 MgSO 4 , 5 glucose, 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 2 glutamine, 10 sodium butyrate, 4 sodium lactate, adjusted to pH 7.05 at 41C in a siliconized Erlenmeyer flask (200 ml). The tubule suspension containing 0.5-1.0 mg/ml of protein determined by the Lowry method was gassed on ice for 5 min with 95% O 2 /5% CO 2 . Tubules were placed in a shaking water bath at 371C for 10 min. Aliquots were washed three times in PBS and centrifuged (1 min at 700 g). Thereafter, proximal tubules were incubated with 500 nmol OAG dissolved in PBS at 201C on a rocker for 10 min. The supernatant was collected, immediately stored on ice and 0.6 mol/l perchloric acid added for protein precipitation. The samples were gently stirred for 1 min and centrifuged at 2100 g for 10 min at 41C. The supernatant was collected, immediately adjusted to pH 10 with 10 mol/l KOH, and samples were frozen at À201C until measurement of diadenosine polyphosphates. For control experiments, proximal tubules were treated similarly, but OAG was omitted and proximal tubules were only incubated with PBS.
Statistical analysis
Data are presented as mean7s.e.m. Results were tested for statistical significance using the Mann-Whitney U-test.
